436 related articles for article (PubMed ID: 11004259)
1. Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy.
Robinson MR; Reed G; Csaky KG; Polis MA; Whitcup SM
Am J Ophthalmol; 2000 Jul; 130(1):49-56. PubMed ID: 11004259
[TBL] [Abstract][Full Text] [Related]
2. Immune recovery uveitis.
Kuppermann BD; Holland GN
Am J Ophthalmol; 2000 Jul; 130(1):103-6. PubMed ID: 11004267
[No Abstract] [Full Text] [Related]
3. Immune recovery vitritis and uveitis in AIDS: clinical predictors, sequelae, and treatment outcomes.
Karavellas MP; Azen SP; MacDonald JC; Shufelt CL; Lowder CY; Plummer DJ; Glasgow B; Torriani FJ; Freeman WR
Retina; 2001; 21(1):1-9. PubMed ID: 11217922
[TBL] [Abstract][Full Text] [Related]
4. Long-term posterior and anterior segment complications of immune recovery uveitis associated with cytomegalovirus retinitis.
Karavellas MP; Song M; Macdonald JC; Freeman WR
Am J Ophthalmol; 2000 Jul; 130(1):57-64. PubMed ID: 11004260
[TBL] [Abstract][Full Text] [Related]
5. Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis.
Song MK; Azen SP; Buley A; Torriani F; Cheng L; Chaidhawangul S; Ozerdem U; Scholz B; Freeman WR
Am J Ophthalmol; 2003 Oct; 136(4):696-702. PubMed ID: 14516810
[TBL] [Abstract][Full Text] [Related]
6. Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy.
Nguyen QD; Kempen JH; Bolton SG; Dunn JP; Jabs DA
Am J Ophthalmol; 2000 May; 129(5):634-9. PubMed ID: 10844056
[TBL] [Abstract][Full Text] [Related]
7. Valganciclovir therapy for immune recovery uveitis complicated by macular edema.
Kosobucki BR; Goldberg DE; Bessho K; Koh HJ; Rodanant N; Labree L; Cheng L; Schrier RD; Azen SP; Freeman WR
Am J Ophthalmol; 2004 Apr; 137(4):636-8. PubMed ID: 15059701
[TBL] [Abstract][Full Text] [Related]
8. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela.
Arevalo JF; Garcia RA; Mendoza AJ
Eur J Ophthalmol; 2005; 15(5):610-8. PubMed ID: 16167292
[TBL] [Abstract][Full Text] [Related]
9. Immune recovery uveitis in AIDS patients with cytomegalovirus retinitis treated with highly active antiretroviral therapy in Venezuela.
Arevalo JF; Mendoza AJ; Ferretti Y
Retina; 2003 Aug; 23(4):495-502. PubMed ID: 12972761
[TBL] [Abstract][Full Text] [Related]
10. Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome.
Karavellas MP; Lowder CY; Macdonald C; Avila CP; Freeman WR
Arch Ophthalmol; 1998 Feb; 116(2):169-75. PubMed ID: 9488268
[TBL] [Abstract][Full Text] [Related]
11. Intraocular viral and immune pathogenesis of immune recovery uveitis in patients with healed cytomegalovirus retinitis.
Schrier RD; Song MK; Smith IL; Karavellas MP; Bartsch DU; Torriani FJ; Garcia CR; Freeman WR
Retina; 2006 Feb; 26(2):165-9. PubMed ID: 16467672
[TBL] [Abstract][Full Text] [Related]
12. Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis.
Zegans ME; Walton RC; Holland GN; O'Donnell JJ; Jacobson MA; Margolis TP
Am J Ophthalmol; 1998 Mar; 125(3):292-300. PubMed ID: 9512145
[TBL] [Abstract][Full Text] [Related]
13. Cystoid macular oedema and cytomegalovirus retinitis in patients with HIV disease treated with highly active antiretroviral therapy.
Cassoux N; Lumbroso L; Bodaghi B; Zazoun L; Katlama C; LeHoang P
Br J Ophthalmol; 1999 Jan; 83(1):47-9. PubMed ID: 10209434
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Whitcup SM
JAMA; 2000 Feb; 283(5):653-7. PubMed ID: 10665706
[TBL] [Abstract][Full Text] [Related]
15. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis.
Kempen JH; Min YI; Freeman WR; Holland GN; Friedberg DN; Dieterich DT; Jabs DA;
Ophthalmology; 2006 Apr; 113(4):684-94. PubMed ID: 16581429
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal triamcinolone acetonide for the treatment of immune recovery uveitis macular edema.
Morrison VL; Kozak I; LaBree LD; Azen SP; Kayicioglu OO; Freeman WR
Ophthalmology; 2007 Feb; 114(2):334-9. PubMed ID: 17270681
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis.
Holbrook JT; Colvin R; van Natta ML; Thorne JE; Bardsley M; Jabs DA;
Am J Ophthalmol; 2011 Oct; 152(4):628-637.e1. PubMed ID: 21742304
[TBL] [Abstract][Full Text] [Related]
18. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes.
Jabs DA; Ahuja A; Van Natta M; Lyon A; Srivastava S; Gangaputra S;
Ophthalmology; 2010 Nov; 117(11):2152-61.e1-2. PubMed ID: 20673591
[TBL] [Abstract][Full Text] [Related]
19. Valganciclovir therapy for immune recovery uveitis complicated by macular edema.
Raj A
Am J Ophthalmol; 2005 Jan; 139(1):216-7; author reply 217. PubMed ID: 15652864
[No Abstract] [Full Text] [Related]
20. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Whitcup SM; Fortin E; Lindblad AS; Griffiths P; Metcalf JA; Robinson MR; Manischewitz J; Baird B; Perry C; Kidd IM; Vrabec T; Davey RT; Falloon J; Walker RE; Kovacs JA; Lane HC; Nussenblatt RB; Smith J; Masur H; Polis MA
JAMA; 1999 Nov; 282(17):1633-7. PubMed ID: 10553789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
